EYEBIOTECH LIMITED

13503296
Active London

Research and experimental development on biotechnology

20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EYEBIOTECH LIMITED

13503296

Research and experimental development on biotechnology

Founded 9 Jul 2021 Active London, England 20 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 3 Apr 2026 Next due 31 Dec 2025 6 months overdue
Confirmation Submitted 21 Jul 2025 Next due 22 Jul 2026 1 month remaining
Net assets £43M
Total assets £49M
Total Liabilities £7M
Charges None No charges registered

Contact & Details

Contact

Registered Address

120 Moorgate London EC2M 6UR England

Email

info@example.com

Website

www.example.com

Full company profile for EYEBIOTECH LIMITED (13503296), an active life sciences and medical technology company based in London, England. Incorporated 9 Jul 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type group
Next accounts 31 Dec 2024
Due by 31 Dec 2025 6 months overdue

Net Assets, Total Assets & Total Liabilities (2023–2023)

Cash in Bank

£38.63M

Net Assets

£42.70M

Total Liabilities

£6.56M

Turnover

N/A

Employees

20

Debt Ratio

13%

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2022Series A
Investor 2Feb 2022Series A
Investor 3Feb 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

26 Allotments 148,950,234 Shares £103.56m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Jul 20242,026,343£2.25m£1.11
11 Jul 20241,558,442£1.35m£0.866
11 Jul 2024322,000£74k£0.23
11 Jul 20243,813,677£381.368£0
11 Jul 20243,420,821£342.082£0

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (46)

Msd International Business Gmbh
63.8%
95,000,000
Msd International Business Gmbh
18.2%
27,174,811

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Merck & Co., Inc.

United States Of America

Active
Notified 11 Jul 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

EYEBIOTECH LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Apr 2026AccountsAnnual accounts made up to 31 Dec 2024
13 Mar 2026AddressChange Sail Address Company With Old Address New Address
21 Jul 2025Confirmation StatementConfirmation statement made on 8 Jul 2025 with updates
15 May 2025ResolutionResolutions
12 May 2025IncorporationMemorandum Articles
3 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2024

13 Mar 2026 Address

Change Sail Address Company With Old Address New Address

21 Jul 2025 Confirmation Statement

Confirmation statement made on 8 Jul 2025 with updates

15 May 2025 Resolution

Resolutions

12 May 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

2 months ago on 3 Apr 2026

Change Sail Address Company With Old Address New Address

3 months ago on 13 Mar 2026

Confirmation statement made on 8 Jul 2025 with updates

11 months ago on 21 Jul 2025

Resolutions

1 years ago on 15 May 2025

Memorandum Articles

1 years ago on 12 May 2025